FI920192A0 - Substituerade 1,2,3,4-tetrahydro -cyklopent/b/indoler, 1,2,3,3a,4,8a-hexahydrocyklopent/b/indoler och motsvarande foereningar, mellanprodukter och foerfarande foer deras framstaellning och deras anvaendning som laekemedel. - Google Patents

Substituerade 1,2,3,4-tetrahydro -cyklopent/b/indoler, 1,2,3,3a,4,8a-hexahydrocyklopent/b/indoler och motsvarande foereningar, mellanprodukter och foerfarande foer deras framstaellning och deras anvaendning som laekemedel.

Info

Publication number
FI920192A0
FI920192A0 FI920192A FI920192A FI920192A0 FI 920192 A0 FI920192 A0 FI 920192A0 FI 920192 A FI920192 A FI 920192A FI 920192 A FI920192 A FI 920192A FI 920192 A0 FI920192 A0 FI 920192A0
Authority
FI
Finland
Prior art keywords
indoler
hexahydrocyklopent
substituerade
cyclopent
tetrahydro
Prior art date
Application number
FI920192A
Other languages
English (en)
Other versions
FI102174B1 (fi
FI102174B (fi
FI920192A (fi
Inventor
Helen Hu Ong
Gerard Joseph O'malley
Michael Clayton Merriman
Mark Gabriel Palermo
Original Assignee
Hoechst Roussel Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Roussel Pharma filed Critical Hoechst Roussel Pharma
Publication of FI920192A0 publication Critical patent/FI920192A0/fi
Publication of FI920192A publication Critical patent/FI920192A/fi
Priority to FI970397A priority Critical patent/FI106713B/fi
Priority to FI970396A priority patent/FI107150B/fi
Application granted granted Critical
Publication of FI102174B1 publication Critical patent/FI102174B1/fi
Publication of FI102174B publication Critical patent/FI102174B/fi

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/56Ring systems containing three or more rings
    • C07D209/80[b, c]- or [b, d]-condensed
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/26Psychostimulants, e.g. nicotine, cocaine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Psychiatry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Hospice & Palliative Care (AREA)
  • Pain & Pain Management (AREA)
  • Indole Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
FI920192A 1991-01-18 1992-01-16 Menetelmä 1,2,3,4-tetrahydro- ja 1,2,3,3a,4,8b-heksahydrosyklopent£b|i ndolijohdannaisten valmistamiseksi FI102174B (fi)

Priority Applications (2)

Application Number Priority Date Filing Date Title
FI970397A FI106713B (fi) 1991-01-18 1997-01-30 Substituoituja 1,4-dihydrosyklopent[b]indol-3(2H)-onijohdannaisia
FI970396A FI107150B (fi) 1991-01-18 1997-01-30 Menetelmä terapeuttisesti aktiivisten iminosubstituoitujen syklopent[b]indolijohdannaisten valmistamiseksi

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US64295291 1991-01-18
US07/642,952 US5100891A (en) 1991-01-18 1991-01-18 Substituted 1,2,3,4-tetrahydrocyclopent[b]indoles, 1,2,3,3a,4,8a-hexahydrocyclopent[B]indoles and related compounds

Publications (4)

Publication Number Publication Date
FI920192A0 true FI920192A0 (fi) 1992-01-16
FI920192A FI920192A (fi) 1992-07-19
FI102174B1 FI102174B1 (fi) 1998-10-30
FI102174B FI102174B (fi) 1998-10-30

Family

ID=24578739

Family Applications (2)

Application Number Title Priority Date Filing Date
FI920192A FI102174B (fi) 1991-01-18 1992-01-16 Menetelmä 1,2,3,4-tetrahydro- ja 1,2,3,3a,4,8b-heksahydrosyklopent£b|i ndolijohdannaisten valmistamiseksi
FI20001775A FI107919B (fi) 1991-01-18 2000-08-10 Välituotteina käyttökelpoisia iminosubstituoituja syklopent[b]indolijohdannaisia

Family Applications After (1)

Application Number Title Priority Date Filing Date
FI20001775A FI107919B (fi) 1991-01-18 2000-08-10 Välituotteina käyttökelpoisia iminosubstituoituja syklopent[b]indolijohdannaisia

Country Status (26)

Country Link
US (1) US5100891A (fi)
EP (1) EP0496314B1 (fi)
JP (1) JP2665422B2 (fi)
KR (1) KR100230881B1 (fi)
AT (1) ATE158790T1 (fi)
AU (1) AU650315B2 (fi)
BR (1) BR9200171A (fi)
CA (1) CA2059610C (fi)
CZ (1) CZ282732B6 (fi)
DE (1) DE69222444T2 (fi)
DK (1) DK0496314T3 (fi)
ES (1) ES2109953T3 (fi)
FI (2) FI102174B (fi)
GR (1) GR3025318T3 (fi)
HU (1) HUT67027A (fi)
IE (1) IE920149A1 (fi)
IL (1) IL100693A0 (fi)
MX (1) MX9200206A (fi)
NO (1) NO178397C (fi)
NZ (1) NZ241305A (fi)
PH (1) PH31429A (fi)
PL (2) PL169417B1 (fi)
RO (1) RO112505B1 (fi)
RU (1) RU2077530C1 (fi)
TW (1) TW198024B (fi)
ZA (1) ZA92341B (fi)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5298626A (en) * 1991-01-18 1994-03-29 Hoechst-Roussel Pharmaceuticals Incorporated Select cyclopent[b]indoles
US5350762A (en) * 1993-03-08 1994-09-27 Hoechst-Roussel Pharmaceuticals Incorporated Tetrahydrocyclopent[B]indole methanamines and related compounds
ES2149742T1 (es) * 1997-07-03 2000-11-16 Asahi Chemical Ind Nuevos compuestos triciclicos que tienen anillos saturados y composiciones medicinales que contienen los mismos.
UA70961C2 (uk) * 1998-10-06 2004-11-15 Янссен Фармацевтика Н.В. ТРИЦИКЛІЧНІ <font face="Symbol">D</font>3-ПІПЕРИДИНИ, КОМПОЗИЦІЯ НА ЇХ ОСНОВІ ТА СПОСІБ ЇХ ОДЕРЖАННЯ (ВАРІАНТИ)
UA70334C2 (en) * 1998-10-06 2004-10-15 Janssen Pharmaceutica N V Jans BENZOTHIENO[3,2-c]PYRIDINES AS a2 ANTAGONISTS BENZOTHIENO[3,2-c]PYRIDINES AS a2 ANTAGONISTS
UA69420C2 (uk) * 1998-10-06 2004-09-15 Янссен Фармацевтика Н.В. ТРИЦИКЛІЧНІ <font face="Symbol">D3</font>-ПІПЕРИДИНИ ЯК <font face="Symbol">a<sub></font>2</sub>-АНТАГОНІСТИ
IT1317926B1 (it) * 2000-11-03 2003-07-15 Sigma Tau Ind Farmaceuti Derivati triciclici dell'indolo ad attivita' antiangiogenica.
DE602004017326D1 (de) 2003-06-10 2008-12-04 Smithkline Beecham Corp Tetrahydrocarbazolderivate und deren pharmazeutische verwendung
EP1646610B1 (en) * 2003-06-12 2009-07-22 SmithKline Beecham Corporation Tetrahydrocarbazole derivatives and their pharmaceutical use
CA2588384A1 (en) * 2004-11-23 2006-06-22 Ptc Therapeutics, Inc. Tetrahydrocarbazoles as active agents for inhibiting vegf production by translational control
GB2422828A (en) * 2005-02-03 2006-08-09 Hunter Fleming Ltd Tricyclic cytoprotective compounds comprising an indole residue
WO2013139929A1 (en) * 2012-03-22 2013-09-26 Ludwig-Maximilians-Universität München Novel means and methods for treating diseases of the central nervous system, metabolic and cardiac diseases and aging
KR20140013471A (ko) 2012-07-24 2014-02-05 주식회사 쎄코 진공증착용 발열조립체 및 이를 구비하는 진공증착장치
US10882821B1 (en) 2017-09-26 2021-01-05 The Board Of Trustees Of The Leland Stanford Junior University Enantiomeric compound for the reduction of the deleterious activity of extended nucleotide repeat containing genes

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3514462A (en) * 1966-10-21 1970-05-26 Upjohn Co 1 and 2 ethoxy 3,4,5,10 - tetrahydroazepino(3,4-b) and (2,3-b)indoles and corresponding amino derivatives thereof
US3595874A (en) * 1969-02-28 1971-07-27 Upjohn Co 3,4,5,10-tetrahydroazepino(2,3-b)indol-5a (2h)-ols
BE787537A (fr) * 1971-08-16 1973-02-14 Sterling Drug Inc Tetrahydrocarbazoles
SU482086A1 (ru) * 1973-11-30 1976-03-15 Всесоюзный Научно-Исследовательски% Химико-Фармацевтический Институт Им.С.Орджоникидзе Способ получени производных 1- -амино1,2,3,4-тетрагидрокарбазола
FR2275202A1 (fr) * 1974-06-18 1976-01-16 Ayerst Mckenna & Harrison Derives tricycliques d'alcoylamines et preparation de ceux-ci
US4254134A (en) * 1978-03-17 1981-03-03 Endo Laboratories, Inc. Antidepressant 2-amino- and -2-(substituted amino)-cis-hexahydro-carbazoles

Also Published As

Publication number Publication date
CS12992A3 (en) 1992-08-12
GR3025318T3 (en) 1998-02-27
DE69222444T2 (de) 1998-06-04
PH31429A (en) 1998-11-03
DE69222444D1 (de) 1997-11-06
NO920235L (no) 1992-07-20
BR9200171A (pt) 1992-10-06
RO112505B1 (ro) 1997-10-30
MX9200206A (es) 1992-08-01
EP0496314A1 (en) 1992-07-29
JPH04334367A (ja) 1992-11-20
US5100891A (en) 1992-03-31
NZ241305A (en) 1994-10-26
AU1027992A (en) 1992-07-23
CA2059610C (en) 2002-04-02
TW198024B (fi) 1993-01-11
AU650315B2 (en) 1994-06-16
IE920149A1 (en) 1992-07-29
FI20001775A (fi) 2000-08-10
ZA92341B (en) 1992-09-30
ES2109953T3 (es) 1998-02-01
EP0496314B1 (en) 1997-10-01
FI107919B (fi) 2001-10-31
NO178397C (no) 1996-03-20
CA2059610A1 (en) 1992-07-19
CZ282732B6 (cs) 1997-09-17
NO920235D0 (no) 1992-01-17
KR100230881B1 (ko) 1999-11-15
JP2665422B2 (ja) 1997-10-22
FI102174B1 (fi) 1998-10-30
IL100693A0 (en) 1992-09-06
ATE158790T1 (de) 1997-10-15
PL293209A1 (en) 1993-04-05
FI102174B (fi) 1998-10-30
HUT67027A (en) 1995-01-30
PL167465B1 (pl) 1995-09-30
HU9200172D0 (en) 1992-04-28
NO178397B (no) 1995-12-11
RU2077530C1 (ru) 1997-04-20
FI920192A (fi) 1992-07-19
PL296651A1 (en) 1993-07-26
KR920014777A (ko) 1992-08-25
DK0496314T3 (da) 1998-05-18
PL169417B1 (pl) 1996-07-31

Similar Documents

Publication Publication Date Title
FI920192A (fi) Substituerade 1,2,3,4-tetrahydro -cyklopent/b/indoler, 1,2,3,3a,4,8a-hexahydrocyklopent/b/indoler och motsvarande foereningar, mellanprodukter och foerfarande foer deras framstaellning och deras anvaendning som laekemedel.
FI952481A0 (fi) Substituoituja 3-(aminoalkyyliamino)-1,2-bentsisoksatoleja ja niihin liittyviä yhdisteitä
ATE47137T1 (de) Verfahren zur herstellung von taxol und von desazetyl-10-taxol.
FI922592A (fi) (arylalkylpiperidin-4-yl)metyl)-2a,3,4,5-tetra-hydro-1(2h)-acetnaftylen-1-oner och motsvarande foereningar, foerfarande foer deras framstaellning och deras anvaendning som laekemedel
DE69533214D1 (de) 2,3-Dihydro-1H-isoindolderivate, Verfahren zu ihrer Herstellung und ihre Verwendung als Hemmer der Serotoninwiederaufnahme
DE69709252T2 (de) Coumarin-Derivate, Verfahren zu deren Herstellung und deren Verwendung
DK0758336T3 (da) Fremgangsmåde til fremstilling af 1-(3-trialkylsilylphenyl)-2,2,2-trifluorethanonderivater
ES533657A0 (es) Un procedimiento para la preparacion de nuevos derivados de pirrolo-(2,1-a)isoquilonina.
DE69724216D1 (de) Pyridin-Zwischenprodukte, verwendbar zur Herstellung von Beta-adrenergischen Rezeptor-Agonisten
FI875602A0 (fi) Optiskt aktivt tetrahydro-2-furanonderivat saosom miksobicid.
ES2078288T3 (es) Isomeros de 1,4-dihidro-2,6-dimetil-4-(3-nitrofenil)-5-nitropiridina-3-carboxilato de 1-azabiciclo(2.2.2)oct-3-ilo.

Legal Events

Date Code Title Description
GB Transfer or assigment of application

Owner name: HOECHST MARION ROUSSEL, INC.